After the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by the European Commission, as a booster for the prevention of COVID-19 in adults 18 years of age and older.
Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission
November 16, 2022

Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022
Bayer with continued strong performance
November 10, 2022